Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Portfolio > ETFs > Broad Market

First bionic eye sees light of day in U.S.

X
Your article was successfully shared with the contacts you provided.

Bionic eyes are no longer the stuff of science fiction; after years of research, the first bionic eye is poised to hit the U.S. market. A company called Second Sight Medical Products has developed their Argus II Retinal Prosthesis System which consists of 60 electrodes. Implanted in the retina, and with glasses fitted with a special mini-camera, the retinal prosthesis would restore sight to those with retinitis pigmentosa, a rare genetic disease affecting some 100,000 people in the U.S. The Argus is poised for FDA approval soon, and after that, bionic eyes will become commercial available.